🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 98421X102
- Market Cap
- Micro Cap · $7 Million
- Previous Symbol
- XYN (changed 5/15/2019)
- Previous Name
- Bison Capital Acquisition Corp.
Business: Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage oncology-focused biopharmaceutical company. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma (in combination with pazopanib) and non-Hodgkin’s lymphoma (as a single agent).
Company Contact
- CEO
- Mark Xu
- CFO
- Yinglin Mark Xu
- Headquarters
- 3500 South DuPont Highway, Suite SS101, Dover, DE 19901, USA
- Investor Relations
- angela.feng@xynomicpharma.com